Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

Published:2015-08 Issue:2 Volume:149 Page:389-397.e10
ISSN:0016-5085
Container-title:Gastroenterology
language:en
Short-container-title:Gastroenterology

Author:

Angulo Paul,Kleiner David E.,Dam-Larsen Sanne,Adams Leon A.,Bjornsson Einar S.,Charatcharoenwitthaya Phunchai,Mills Peter R.,Keach Jill C.,Lafferty Heather D.,Stahler Alisha,Haflidadottir Svanhildur,Bendtsen Flemming

Funder

National Institutes of Health

National Cancer Institute

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference26 articles.

1. Epidemiology and natural history of nonalcoholic fatty liver disease (NAFLD);Bellentani;Ann Hepatol,2009

2. Cryptogenic cirrhosis: clinical characterization and risk factors for underlying disease;Caldwell;Hepatology,1999

3. Prevalence and indicators of portal hypertension in patients with nonalcoholic fatty liver disease;Mendes;Clin Gastroenterol Hepatol,2012

4. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study;Bhala;Hepatology,2011

5. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace;Baffy;J Hepatol,2012

Cited by 2322 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steatotic liver disease in the context of hematological malignancies and anti-neoplastic chemotherapy;Metabolism;2024-11

2. Helicobacter pylori cagA/vacAs1-m1 strain is associated with high risk of fibrosis in metabolic-dysfunction-associated steatotic liver disease;Annals of Hepatology;2024-11

3. Hepatic stearoyl-CoA desaturase-1 deficiency induces fibrosis and hepatocellular carcinoma-related gene activation under a high carbohydrate low fat diet;Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids;2024-10

4. Natural history and progression of metabolic dysfunction-associated steatotic liver disease;The Lancet Gastroenterology & Hepatology;2024-10

5. Digital quantitation of bridging fibrosis and septa reveals changes in natural history and treatment not seen with conventional histology;Liver International;2024-09-09